CARGO Therapeutics Inc [NASDAQ: CRGX] closed the trading session at $4.49 on 2025-07-22. The day’s price range saw the stock hit a low of $4.4, while the highest price level was $4.49.
The stocks have a year to date performance of -73.65 percent and weekly performance of -2.60 percent. The stock has been moved at -63.76 percent over the last six months. The stock has performed 5.15 percent around the most recent 30 days and changed -2.39 percent over the most recent 3-months.
If compared to the average trading volume of 1.22M shares, CRGX reached to a volume of 7717504 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about CARGO Therapeutics Inc [CRGX]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CRGX shares is $5.33 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CRGX stock is a recommendation set at 3.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
William Blair have made an estimate for CARGO Therapeutics Inc shares, keeping their opinion on the stock as Mkt Perform, with their previous recommendation back on January 30, 2025. While these analysts kept the previous recommendation, Truist raised their target price from $32 to $7. The new note on the price target was released on January 30, 2025, representing the official price target for CARGO Therapeutics Inc stock. Previously, the target price had yet another drop from $34 to $4, while Piper Sandler kept a Neutral rating on CRGX stock.
The Price to Book ratio for the last quarter was 0.73, with the Price to Cash per share for the same quarter was set at 6.91.
CRGX stock trade performance evaluation
CARGO Therapeutics Inc [CRGX] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -2.60. With this latest performance, CRGX shares gained by 5.15% in over the last four-week period, additionally sinking by -63.76% over the last 6 months – not to mention a drop of -68.86% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CRGX stock in for the last two-week period is set at 52.69, with the RSI for the last a single of trading hit 0.11, and the three-weeks RSI is set at 0.15 for CARGO Therapeutics Inc [CRGX]. The present Moving Average for the last 50 days of trading for this stock 4.33, while it was recorded at 4.56 for the last single week of trading, and 9.39 for the last 200 days.
CARGO Therapeutics Inc (CRGX) Capital Structure & Debt Analysis
According to recent financial data for CARGO Therapeutics Inc. ( CRGX), the Return on Equity (ROE) stands at -65.94%, highlighting a negative impact on investor capital. The Return on Assets (ROA) is -55.12%, reflecting the company’s efficiency in generating profits from its assets. Additionally, CARGO Therapeutics Inc’s Return on Invested Capital (ROIC) is -69.65%, showcasing its effectiveness in deploying capital for earnings.
CARGO Therapeutics Inc (CRGX) Efficiency & Liquidity Metrics
Based on CARGO Therapeutics Inc’s (CRGX) latest financial statements, the Debt-to-Equity Ratio is 0.11%, indicating its reliance on debt financing relative to shareholder equity.
CARGO Therapeutics Inc (CRGX) Efficiency & Liquidity Metrics
From an operational efficiency perspective, CARGO Therapeutics Inc. (CRGX) effectively leverages its workforce, generating an average of -$1294550.9 per employee. The company’s liquidity position is robust, with a Current Ratio of 6.30% and a Quick Ratio of 6.30%, indicating strong ability to cover short-term liabilities.
Earnings per share (EPS) analysis for CARGO Therapeutics Inc [CRGX] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CRGX. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CARGO Therapeutics Inc go to 32.19%.
CARGO Therapeutics Inc [CRGX]: Institutional Ownership
There are presently around $103.91%, or 104.59% of CRGX stock, in the hands of institutional investors. The top three institutional holders of CRGX stocks are: FMR LLC with ownership of 6.88 million shares, which is approximately 15.8659%. SAMSARA BIOCAPITAL, LLC, holding 4.42 million shares of the stock with an approximate value of $$72.51 million in CRGX stocks shares; and SAMSARA BIOCAPITAL, LLC, currently with $$66.96 million in CRGX stock with ownership which is approximately 9.4087%.
